Form 4: Axogen EVP & General Counsel Reports Equity Vesting

Axogen, Inc.'s EVP & General Counsel, Marc Began, reported the vesting of performance stock units and restricted stock units, alongside the acquisition of new restricted stock units.

Summary

• Marc A. Began, EVP & General Counsel of Axogen, Inc., reported multiple equity transactions.
• On February 26, 2026, 33,780 shares of common stock vested from performance stock units (PSUs) due to the attainment of performance criteria.
• Concurrently, 8,753 shares were withheld by Axogen, Inc. to cover tax liabilities associated with the PSU vesting, at a price of $31.9 per share.
• On March 1, 2026, 11,250 shares of common stock vested from restricted stock units (RSUs).
• Additionally, 4,427 shares were withheld by Axogen, Inc. for tax liabilities related to the RSU vesting, at a price of $30.65 per share.
• Began also acquired 23,000 new restricted stock units on February 26, 2026, which will vest over four years, with 50% vesting on February 26, 2028, and 25% each subsequent year, fully vesting by February 26, 2030.
• Following these transactions, Began's direct beneficial ownership of common stock increased to 50,135 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as it indicates the successful vesting of performance-based awards, suggesting the company met certain internal targets, and the granting of new long-term incentives aligns executive interests with future growth.

Positives

• Vesting of 33,780 performance stock units (PSUs) indicates the attainment and certification of certain performance criteria by the company.
• Vesting of 11,250 restricted stock units (RSUs) demonstrates continued long-term incentive compensation for a key executive.
• Acquisition of 23,000 new restricted stock units on February 26, 2026, aligns executive incentives with long-term shareholder value.

Negatives

• 8,753 shares of common stock were withheld by the issuer at $31.9 per share to cover tax liabilities from PSU vesting, representing a reduction in the net shares received by the executive.
• 4,427 shares of common stock were withheld by the issuer at $30.65 per share to cover tax liabilities from RSU vesting, further reducing the net shares received.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that the vesting and granting of equity awards to key executives like the EVP & General Counsel are standard practices in the biotechnology and medical device industry. These awards are designed to align executive interests with long-term shareholder value and incentivize performance, a common strategy across publicly traded companies to retain talent and drive strategic objectives.

Related Party Transactions

• The transactions involve the vesting and acquisition of equity awards by Marc A. Began, an executive officer of Axogen, Inc., which are considered related party transactions as part of his compensation.

Stakeholder Impact

• Shareholders: The vesting of performance-based awards could be seen as a positive signal regarding company performance. The granting of new RSUs aligns executive incentives with long-term shareholder value.
• Employees: Reflects standard executive compensation practices, potentially influencing broader compensation strategies.

Next Steps

• Continued vesting of 23,000 restricted stock units (RSUs) on February 26, 2028 (50%), February 26, 2029 (25%), and February 26, 2030 (final 25%).

Key Dates

Recommendation

This Form 4 filing details routine equity compensation events for a key executive, including the vesting of performance and restricted stock units and the grant of new RSUs. While the vesting of performance awards is a positive indicator of internal goal achievement, these are standard compensation activities and do not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than these specific insider transactions.

Keywords

Axogen, AXGN, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units, Performance Stock Units, Equity Vesting, Marc Began, General Counsel